Chromatin modification: A novel insight into BRAF‐independent spontaneous melanoma

E-ISSN： 1755-148x|31|1|9-10

ISSN： 1755-1471

Source： PIGMENT CELL & MELANOMA RESEARCH, Vol.31, Iss.1, 2018-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma

By Chan Xian Yang Singh Alamdeep Osman Narin Piva Terrence J.

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1527-1527

MDPI

Access to resources Recommend Favorite

“Hit‐and‐Run” leaves its mark: Catalyst transcription factors and chromatin modification

BIOESSAYS (ELECTRONIC), Vol. 37, Iss. 8, 2015-08 ,pp. : 851-856

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phosphoproteomic analysis of basal and therapy‐induced adaptive signaling networks in BRAF and NRAS mutant melanoma

PROTEOMICS, Vol. 15, Iss. 2-3, 2015-01 ,pp. : 327-339

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis

PIGMENT CELL & MELANOMA RESEARCH, Vol. 28, Iss. 3, 2015-05 ,pp. : 254-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion

PIGMENT CELL & MELANOMA RESEARCH, Vol. 28, Iss. 5, 2015-09 ,pp. : 607-610

John Wiley & Sons Inc

Access to resources Recommend Favorite